Clinical Trial Update: DANHEART (H-HeFT and Met-HeFT) [Phase 4]

View source ↗

Summary

The DANHEART program's Phase 4 trials (H-HeFT and Met-HeFT) investigating heart failure in patients with diabetes have completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Heart Failure

Snippet

Sponsor: Henrik Wiggers | Conditions: Heart Failure, Diabetes | Phase 4 | Status: COMPLETED